MEDICA GROUP PLC

Report Publication Announcement • Apr 28, 2023

National Storage Mechanism | Additional information

RNS Number : 9390X

Medica Group PLC

28 April 2023

28 April 2023

Medica Group Plc

Publication of Annual Report

Medica Group Plc (LSE:MGP, the "Company"), the UK market leader by revenue in the provision of teleradiology services, today announces that the Company's annual report and accounts (Annual Report) for the year ended 31 December 2022, is now available on the Company's website at:

www.medicagroupplc.com/investors/results-and-reports.

Th Annual Report will be posted to those shareholders who have opted out of electronic communications shortly.

A copy of the Annual Report will also be submitted to the National Storage Mechanism and will be available for inspection in due course at:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism 

Notice of the Company's 2023 Annual General Meeting (AGM) will be posted to shareholders and available on the Company's website in May, and accordingly the Company will publish a further announcement at that time.

or further information, please contact:

Medica Group Plc: Stuart Quin, Chief Executive Officer Richard Jones, Chief Financial Officer	+44 (0)33 33 111 222
FTI Consulting Victoria Foster Mitchell Sam Purewal	+44 (0)20 3727 1000
Liberum (Joint Broker) Phil Walker Richard Lindley	+44 (0)20 3100 2000
Numis (Joint Broker) Freddie Barnfield Duncan Monteith Euan Brown	+44 (0)20 7260 1000

About Medica Group PLC

Medica (LSE:MGP) is an international provider of high-quality telemedicine services. It is the market leader in teleradiology in the UK and Ireland, working with more than 100 NHS Trusts and HSE hospitals in Ireland, in addition to private hospitals, insurance groups and diagnostic imaging companies. Its network of consultant radiologists, radiographers and specialist doctors interpret and report MRI, CT, ultrasound and X-ray images on behalf of healthcare providers, using Medica's bespoke, secure technology platform for fast and responsive delivery. The company's core services include NightHawk, an urgent, out-of-hours offering available to clients 24/7 with dedicated pathways for stroke and major trauma, and Elective, for routine reporting.

In Ireland, Medica carries out patient scanning, as well as reporting, and runs a diabetic retinopathy screening programme for the National Screening Service. Through its US business, RadMD, Medica provides global pharmaceutical and biotech companies, as well as contract research organisations with specialist imaging services for clinical trials. 

For more information, please visit: www.medicagroupplc.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACSFLFESSVITFIV